GENTAMICIN SULFATE-gentamicin S Ulfate Ointment Perrigo New York Inc

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

GENTAMICIN SULFATE- gentamicin s ulfate ointment

Perrigo New York Inc


----------
Gentamicin Sulfate Ointment USP, 0.1%
Rx Only
For Dermatologic Us e Only
Not for Ophthalmic Us e

DESCRIPTION
Gentamicin Sulfate Ointment USP, 0.1% is a wide spectrum antibiotic preparation for topical
administration. Each gram of Gentamicin Sulfate Ointment USP, 0.1% contains Gentamicin Sulfate USP
equivalent to 1 mg of gentamicin base in a base of light mineral oil and white petrolatum, with 0.5 mg
methylparaben and 0.1 mg propylparaben as preservatives.

CLINICAL PHARMACOLOGY
Gentamicin Sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in
primary and secondary bacterial infections of the skin. This product may clear infections that have not
responded to other topical antibiotic agents. In impetigo contagiosa and other primary skin infections,
treatment with a small amount of Gentamicin Sulfate Ointment three to four times daily usually clears the
lesions promptly. In secondary skin infections, the product facilitates the treatment of the underlying
dermatosis by controlling the infection. Bacteria susceptible to the action of Gentamicin Sulfate include
sensitive strains of Streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus
(coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-
negative bacteria, Pseudomonas aeruginosa, Aerobacter aerogens, Escherichia coli, Proteus vulgaris and
Klebsiella pneumoniae.

INDICATIONS AND USAGE


Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis
barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis,
pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including
poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE:
Gentamicin Sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections.
It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by
incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good
results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial
burns, paronychia, infected insect bites and stings, infected lacerations and abrasions and wounds from
minor surgery. Patients sensitive to neomycin can be treated with Gentamicin Sulfate, although regular
observation of patients sensitive to topical antibiotics is advisable when such patients are treated with
any topical antibiotic. Gentamicin sulfate cream is recommended for wet, oozing primary infections, and
greasy, secondary infections, such as postular acne or infected seborrheic dermatitis. Gentamicin
Sulfate Ointment USP, 0.1% helps retain moisture and has been useful in infection on dry eczematous or
psoriatic skin. Gentamicin Sulfate Ointment USP, 0.1% has been used successfully in infants over one
year of age as well as in adults and children.

CONTRAINDICATIONS
Gentamicin Sulfate Ointment USP, 0.1% is contraindicated in individuals with a history of sensitivity
reactions to any of its components.

PRECAUTIONS
Use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including
fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin
Sulfate Ointment USP, 0.1% should be discontinued and appropriate therapy instituted.

ADVERSE REACTIONS
In patients with dermatoses treated with Gentamicin Sulfate, irritation (erythema and pruritus) that did not
usually require discontinuance of treatment has been reported in a small percentage of cases. There was
no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently
with gentamicin on normal skin. Possible photosensitization has been reported in several patients but
could not be elicited in these patients by reapplication of gentamicin followed by exposure to
ultraviolet radiation.

DOSAGE AND ADMINISTRATION


A small amount of Gentamicin Sulfate Ointment USP, 0.1% should be applied gently to lesions three to
four times a day. The area treated may be covered with a gauze dressing, if desired. In impetigo
contagiosa, the crusts should be removed before application of Gentamicin Sulfate Ointment USP, 0.1%
to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid
further contamination of the infected skin. Infected stasis ulcers have responded well to Gentamicin
Sulfate under gelatin packing.

HOW SUPPLIED
Gentamicin Sulfate Ointment USP, 0.1% is available as follows:
15 g tube (NDC 45802-046-35)
30 g tube (NDC 45802-046-11)

STORAGE
Store at 20-25˚C (68-77˚F) [see USP Controlled Room Temperature].
Manufactured By Perrigo
Bronx, NY 10457
Distributed By Perrigo
Allegan, MI 49010 • www.perrigo.com
Rev. 10/12
:1C800 RC J5

Principal Dis play Panel - Carton


Rx Only
Gentamicin Sulfate Ointment USP, 0.1%
NET WT 15 g
The following image is a placeholder representing the product identifier that is either affixed or
imprinted on the drug package label during the packaging operation.

GENTAMICIN SULFATE
gentamicin sulfate ointment

Product Information
Prod uct T yp e HUMAN PRESCRIPTIO N DRUG Ite m Cod e (S ource ) NDC:458 0 2-0 46

Route of Ad minis tration TO PICAL

Active Ing redient/Active Moiety


Ing redient Name Basis o f Streng th Streng th
GENTAMICIN SULFATE (UNII: 8 X738 6 Q RLV) (GENTAMICIN - UNII:T6 Z9 V48 IKG) GENTAMICIN 1 mg in 1 g

Inactive Ing redients


Ing redient Name Streng th
LIGHT MINERAL O IL (UNII: N6 K578 7Q VP)
PETRO LATUM (UNII: 4T6 H12BN9 U)
METHYLPARABEN (UNII: A2I8 C7HI9 T)
PRO PYLPARABEN (UNII: Z8 IX2SC1O H)

Packag ing
# Item Co de Packag e Descriptio n Marketing Start Date Marketing End Date
1 NDC:458 0 2-0 46 -35 1 in 1 CARTO N 0 7/10 /20 0 6
1 15 g in 1 TUBE; Type 0 : No t a Co mbina tio n Pro duc t
2 NDC:458 0 2-0 46 -11 1 in 1 CARTO N 0 8 /28 /20 0 6
2 30 g in 1 TUBE; Type 0 : No t a Co mbina tio n Pro duc t

Marketing Information
Marke ting Cate gory Ap p lication Numb e r or Monograp h Citation Marke ting S tart Date Marke ting End Date
ANDA ANDA0 6 2351 0 7/10 /20 0 6

Labeler - Perrigo New York Inc (078846912)

Revised: 11/2018 Perrigo New York Inc

You might also like